Want to join the conversation?
In 1Q16, $LH invested approx. $100MM in strategic tuck-in deals predominantly focused on esoteric testing such as anatomic pathology which provides critical diagnostic information in the determination of the appropriate course of cancer treatment. Looking ahead, the company's acquisition pipeline remains robust.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?